DIA Biosimilars 2016
Visit Q2 Solutions at this year’s DIA Biosimilars 2016 Conference
About This Event
The development of biosimilars is increasing at a rapid pace in all global regions, including the US with FDA’s approval of multiple biosimilars. With their potential for improving access to effective biological therapies through reduced costs, biosimilars have garnered great interest among industry, regulators, and payers. Biosimilars 2016 will bring together pharmaceutical executives, regulatory affairs professionals, clinical researchers and many more to address issues around biosimilars science, global regulatory pathways, evidence for clinical applications, and education for prescribers and patients that are key to successful uptake of these products.
Visit Q2 Solutions at our booth to learn more about our biosimilars solutions.
We look forward to meeting you in Washington DC.